Europe Poultry Vaccines Market Size, Share, Growth, Trends and Industry Analysis: By Vaccine Type, By Formulation Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application, and Region Forecast 2031
Europe Poultry Vaccines Market size was valued at US$ 350.46 million in 2024 and is expected to reach US$ 636.56 million by 2031, growing at a significant CAGR of 8.9% from 2025-2031. In addition, Europe market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Europe market to better equip clients with possible investment opportunities across the Countries (Country Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Europe market report include suppliers, manufacturers, marketers, policy makers, and agronomists engaged in Europe market activities.
Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Mareks disease, Newcastle disease, and infectious diseases among others. Increase in the demand for healthy meat and poultry products, rise in R&D activities for the innovation and adoption of newer poultry vaccines, increase in the prevalence of avian influenza and Newcastle diseases, and growing awareness about the poultry diseases among veterinary professionals are expected to boost the Europe poultry vaccines market over the forecast period. However, stringent regulatory guidelines for vaccine approvals and high cost for R&D activities may restrain the growth of poultry vaccines market in forthcoming years.
Geographically, Europe poultry vaccines market is segmented into Germany, France, U.K, Italy Spain, Russia, Poland, and Rest of Europe. Germany poultry vaccines market is expected to exhibit significant growth due to rise in population demanding for healthy meat, increase in R&D activities for the innovation of newer vaccines, and rise in prevalence of infectious diseases such as bird flu (according to Germany Agriculture Ministry, about 776,000 poultry are culled between November 2016 to February 2017 due to bird flu). France poultry vaccines market has a significant share in Europe market, which is attributed to escalation in avian influenza outbreak in poultry, acquisitions and mergings between the companies, and launching of newer vaccines by France companies. U.K. poultry vaccines market has a lucrative growth owing to government support for the poultry production, funding from the government organizations for the development of poultry vaccines, and increase in animal welfare expenditure.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2024 |
US$ 350.46 million |
|
Market Size in 2031 |
US$ 636.56 million |
|
By Vaccine Type |
|
|
By Formulation |
|
|
By Application |
|
|
By Country |
|
Download Free Sample Report
The Europe poultry vaccines market size was valued at US$ 350.46 million in 2024 and is projected to grow at a significant CAGR of 8.9% from 2025-2031.
The market covers are the Germany, France, Italy, United Kingdom (UK), Spain
The market key players are the Zoetis (Pfizer, Inc.), Merck & Co. Inc., Boehringer Ingelheim Vetmedica, Elanco, Bayer Animal Health, Ceva Sante Animale, Zydus AHL, C Romvac Company S.A., AniCon Labor GmbH
| 1.Executive Summary |
| 2.Europe Poultry Vaccines Market Introduction |
| 2.1.Europe Poultry Vaccines Market - Taxonomy |
| 2.2.Europe Poultry Vaccines Market - Definitions |
| 2.2.1.Vaccine Type |
| 2.2.2.Application |
| 2.2.3.Formulation |
| 2.2.4.Country |
| 3.Europe Poultry Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Europe Poultry Vaccines Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Europe Poultry Vaccines Market By Vaccine Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Inactivated Vaccines |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Live Attenuated Vaccines |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Recombinant Vaccines |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Europe Poultry Vaccines Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Marek's Disease |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Newcastle Disease |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Infectious Bursal Disease |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Infectious Bronchitis |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Europe Poultry Vaccines Market By Formulation, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Dry Form (Duct) Vaccines |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Liquid Vaccines |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Freeze Dried Vaccines |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Europe Poultry Vaccines Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Germany |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. France |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Italy |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. United Kingdom (UK) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Spain |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.Germany Poultry Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Vaccine Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Inactivated Vaccines |
| 9.1.2.Live Attenuated Vaccines |
| 9.1.3.Recombinant Vaccines |
| 9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Marek's Disease |
| 9.2.2.Newcastle Disease |
| 9.2.3.Infectious Bursal Disease |
| 9.2.4.Infectious Bronchitis |
| 9.2.5.Others |
| 9.3. Formulation Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Dry Form (Duct) Vaccines |
| 9.3.2.Liquid Vaccines |
| 9.3.3.Freeze Dried Vaccines |
| 10.France Poultry Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Inactivated Vaccines |
| 10.1.2.Live Attenuated Vaccines |
| 10.1.3.Recombinant Vaccines |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Marek's Disease |
| 10.2.2.Newcastle Disease |
| 10.2.3.Infectious Bursal Disease |
| 10.2.4.Infectious Bronchitis |
| 10.2.5.Others |
| 10.3. Formulation Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Dry Form (Duct) Vaccines |
| 10.3.2.Liquid Vaccines |
| 10.3.3.Freeze Dried Vaccines |
| 11.Italy Poultry Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Inactivated Vaccines |
| 11.1.2.Live Attenuated Vaccines |
| 11.1.3.Recombinant Vaccines |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Marek's Disease |
| 11.2.2.Newcastle Disease |
| 11.2.3.Infectious Bursal Disease |
| 11.2.4.Infectious Bronchitis |
| 11.2.5.Others |
| 11.3. Formulation Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Dry Form (Duct) Vaccines |
| 11.3.2.Liquid Vaccines |
| 11.3.3.Freeze Dried Vaccines |
| 12.United Kingdom (UK) Poultry Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Inactivated Vaccines |
| 12.1.2.Live Attenuated Vaccines |
| 12.1.3.Recombinant Vaccines |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Marek's Disease |
| 12.2.2.Newcastle Disease |
| 12.2.3.Infectious Bursal Disease |
| 12.2.4.Infectious Bronchitis |
| 12.2.5.Others |
| 12.3. Formulation Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Dry Form (Duct) Vaccines |
| 12.3.2.Liquid Vaccines |
| 12.3.3.Freeze Dried Vaccines |
| 13.Spain Poultry Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Inactivated Vaccines |
| 13.1.2.Live Attenuated Vaccines |
| 13.1.3.Recombinant Vaccines |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Marek's Disease |
| 13.2.2.Newcastle Disease |
| 13.2.3.Infectious Bursal Disease |
| 13.2.4.Infectious Bronchitis |
| 13.2.5.Others |
| 13.3. Formulation Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Dry Form (Duct) Vaccines |
| 13.3.2.Liquid Vaccines |
| 13.3.3.Freeze Dried Vaccines |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Zoetis (Pfizer, Inc.) |
| 14.2.2.Merck & Co. Inc. |
| 14.2.3.Boehringer Ingelheim Vetmedica |
| 14.2.4.Elanco |
| 14.2.5.Bayer Animal Health |
| 14.2.6.Ceva Sante Animale |
| 14.2.7.Zydus AHL |
| 14.2.8.C Romvac Company S.A. |
| 14.2.9.AniCon Labor GmbH |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Sample
